{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:01:32Z","timestamp":1792447292125,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/X033015\/1"],"award-info":[{"award-number":["EP\/X033015\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejpb.2025.114937","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T16:27:21Z","timestamp":1763656041000},"page":"114937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Paclitaxel and rose bengal loaded microbubbles for the ultrasound targeted chemo-sonodynamic therapy of pancreatic cancer"],"prefix":"10.1016","volume":"218","author":[{"given":"Jack","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiran","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McKaig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanta","family":"Kamila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7406-9969","authenticated-orcid":false,"given":"Chloe","family":"McClenaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Nesbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3371-5929","authenticated-orcid":false,"given":"Eleanor","family":"Stride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8274-4959","authenticated-orcid":false,"given":"Jia-Ling","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2397-648X","authenticated-orcid":false,"given":"Anthony P.","family":"McHale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9286-1312","authenticated-orcid":false,"given":"John F.","family":"Callan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2025.114937_b0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"18","key":"10.1016\/j.ejpb.2025.114937_b0010","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114937_b0015","first-page":"135","article-title":"Paclitaxel formulations: challenges and novel delivery options","volume":"2","author":"Desai","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2025.114937_b0020","doi-asserted-by":"crossref","unstructured":"Gelderblom, H.; Verweij, J.; Nooter, K.; Sparreboom, A. Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 2001, 37(13), 1590\u20131598.","DOI":"10.1016\/S0959-8049(01)00171-X"},{"issue":"4","key":"10.1016\/j.ejpb.2025.114937_b0025","first-page":"832","article-title":"The winning formulation: the development of paclitaxel in pancreatic cancer","volume":"27","author":"Ma","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114937_b0030","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1158\/1078-0432.CCR-04-2291","article-title":"Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol)","volume":"11","author":"Sparreboom","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejpb.2025.114937_b0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejpb.2023.10.012","article-title":"Ultrasound targeted MB destruction using docetaxel and Rose Bengal loaded MBs for targeted chemo-sonodynamic therapy treatment of prostate cancer","volume":"192","author":"McKaig","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114937_b0040","first-page":"1","article-title":"Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single MB formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted MB destruction","volume":"164","author":"Logan","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"10.1016\/j.ejpb.2025.114937_b0045","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.addr.2008.03.005","article-title":"MBs in ultrasound-triggered drug and gene delivery","volume":"60","author":"Hernot","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2025.114937_b0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev.bioeng.8.061505.095852","article-title":"Ultrasound MB contrast agents: Fundamentals and application to gene and drug delivery","volume":"9","author":"Ferrara","year":"2007","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114937_b0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.ejpb.2025.114937_b0060","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.ultrasmedbio.2006.03.017","article-title":"Therapeutic effects of paclitaxel-containing ultrasound contrast agents","volume":"32","author":"Tartis","year":"2006","journal-title":"Ultrasound Med. Biol."},{"issue":"4_suppl","key":"10.1016\/j.ejpb.2025.114937_b0065","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1177\/0192623312438738","article-title":"International harmonization of toxicologic pathology nomenclature: an overview and review of basic principles","volume":"40","author":"Mann","year":"2012","journal-title":"Toxicol. Pathol."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114937_b0070","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"67","key":"10.1016\/j.ejpb.2025.114937_b0075","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1039\/c2cc33913g","article-title":"Microbubble\u2013sonosensitiser conjugates as therapeutics in sonodynamic therapy","volume":"48","author":"Nomikou","year":"2012","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114937_b0080","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1158\/2159-8290.CD-11-0242","article-title":"Nab-paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer","volume":"2","author":"Frese","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejpb.2025.114937_b0085","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1093\/carcin\/bgt227","article-title":"Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer","volume":"34","author":"Awasthi","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejpb.2025.114937_b0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2016.10.007","article-title":"A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer","volume":"243","author":"Dimcevski","year":"2016","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:23:06Z","timestamp":1766139786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125003157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":18,"alternative-id":["S0939641125003157"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114937","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paclitaxel and rose bengal loaded microbubbles for the ultrasound targeted chemo-sonodynamic therapy of pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114937"}}